Roth MKM lowered the firm’s price target on Astera Labs to $60 from $85 and keeps a Buy rating on the shares. The company’s Q2 results marked strong content ramp across AI infrastructure buildout, though the firm is reducing its price target to reflect adjusting market valuations, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALAB: